ONCIN.OL — Oncoinvent

Healthcare · Oslo Børs. Last price 70.00 NOK (-1.69% on the day). Raven's AI 12-month target for Oncoinvent (85.00 NOK) is 22.7% below the analyst median (110.00 NOK, 1 analyst). Updated 2026-10-09.

Paper-trade Oncoinvent free with 100 000 fake NOK and compete with other players on Raven Trading Game.

Raven’s AI view

Raven's AI sets a 12-month target of 85.00 NOK (+19.38% from 71.20 when it was set on 2026-10-09). Conviction: medium.

Catalysts: Capital structure clarity; Clinical progress

Risks: High volatility (77%); Dilution from capital raises; Weak MA50 positioning

Oslo Børs announcements

• 2026-10-08: Oncoinvent ASA - Cancellation of subsequent repair offering
• 2026-10-02: Oncoinvent ASA - Disclosure of large shareholding
• 2026-09-30: Oncoinvent ASA - Mandatory notification of trade - Return of lent shares following Private Placement
• 2026-09-30: Oncoinvent ASA - New share capital registered
• 2026-09-30: Oncoinvent to present three abstracts at EANM and ESMO 2026

Insider trades

• 2026-09-23: Oncoinvent ASA - Mandatory notification of trade
• 2026-09-22: Oncoinvent ASA - Mandatory notification of trade

Home · All Oslo Børs stocks · Leaderboard · News · Learn: stock market courses · AI insights · Raven bot · DNB Markets bot · Mistral bot · Maven bot

More Healthcare stocks: ABS Arctic Bioscience · ABTEC Aqua Bio Technology · AZT ArcticZymes Technologies · CODE CodeLab Capital · CONTX ContextVision · CRNA Circio Holding ASA · EXTX EXACT Therapeutics · INDCT Induct